Agios Pharmaceuticals, Inc. (AGIO) SEC Filings — 2024
16 SEC filings for Agios Pharmaceuticals, Inc. (AGIO) in 2024.
Filings
- Agios Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Agios Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- Agios Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Oct 31, 2024
- Agios Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 1, 2024
- Agios Pharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · Jun 20, 2024
- Agios Pharmaceuticals Files 8-K with Material Agreement — 8-K · May 28, 2024
- AGIOS PHARMACEUTICALS, INC. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 2, 2024
- AGIOS PHARMACEUTICALS, INC. DEF 14A Filing — DEF 14A · Apr 26, 2024
- Agios Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 15, 2024
- Agios Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Agios Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Vanguard Maintains 12.1% Stake in Agios Pharmaceuticals — SC 13G/A · Feb 12, 2024
- Farallon Capital Exits Agios Pharma Stake as of Dec 31, 2023 — SC 13G/A · Feb 8, 2024
- BlackRock Amends Agios Pharma Stake, Signals Passive Investment — SC 13G/A · Jan 25, 2024
- State Street Corp. Maintains Significant Stake in Agios Pharma — SC 13G/A · Jan 22, 2024
- Agios Pharma Files Routine 8-K for Regulatory Compliance — 8-K · Jan 8, 2024